Anna M. Dahlin
- Oncology top 5%
- Cancer Research top 5%
- MicroRNA in disease regulation 3
- Immunology top 10%
-
- Genetic factors in colorectal cancer 4
-
- Ferroptosis and cancer prognosis 3
- Prostate Cancer Diagnosis and Treatment 3
- Prostate Cancer Treatment and Research 3
-
- Glioma Diagnosis and Treatment 8
-
- Epigenetics and DNA Methylation 8
-
- Radiomics and Machine Learning in Medical Imaging 3
- Co-authors
- Richard PalmqvistÅke ÖbergMartin RutegårdSofia EdinMaria L. WikbergBethany Van GuelpenMaria L. HenrikssonPer‐Arne Oldenborg
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- SwedenUnited StatesDenmark
In The Last Decade
Anna M. Dahlin
36 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 104
- Oncology 917
- Cancer Research 337
- Immunology 383
- Pathology and Forensic Medicine 306
- Pulmonary and Respiratory Medicine 457
Countries citing papers authored by Anna M. Dahlin
This map shows the geographic impact of Anna M. Dahlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Dahlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Dahlin more than expected).
Fields of papers citing papers by Anna M. Dahlin
This network shows the impact of papers produced by Anna M. Dahlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Dahlin. The network helps show where Anna M. Dahlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna M. Dahlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 8 | |
| 3 | 2020 | 9 | |
| 4 | 2018 | 7 | |
| 5 | 2016 | 28 | |
| 6 | 2016 | 7 | |
| 7 | 2015 | 15 | |
| 8 | 2015 | 14 | |
| 9 | 2013 | 173 | |
| 10 | 2013 | 134 | |
| 11 | 2013 | 139 | |
| 12 | 2012 | 387 | |
| 13 | 2011 | 116 | |
| 14 | 2011 | 61 | |
| 15 | 2011 | 36 | |
| 16 | 2010 | 141 | |
| 17 | 2010 | 151 | |
| 18 | 2009 | 33 | |
| 19 | 2007 | 31 | |
| 20 | 2005 | 4 |
About Anna M. Dahlin
Anna M. Dahlin is a scholar working on Genetics, Cancer Research and Oncology, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (8 papers), Genetic factors in colorectal cancer (4 papers), MicroRNA in disease regulation (3 papers), Ferroptosis and cancer prognosis (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Oncology (917 citations), Cancer Research (337 citations) and Immunology (383 citations). Anna M. Dahlin has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Richard Palmqvist, Åke Öberg, Martin Rutegård, Sofia Edin, Maria L. Wikberg, Bethany Van Guelpen, Maria L. Henriksson, Per‐Arne Oldenborg, Roger Stenling and Vincy Eklöf. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.